See ASH 2011 - San Diego - CML - Chronic Myeloid Leukemia
2011 ASH Annual Meeting and Exposition - December 10-13, 2011 - CML - Chronic Myeloid Leukemia
Started by
cousineg
, Dec 04 2011 05:03 PM
1 reply to this topic
#2
scuba
-
- Members
-
- 1,044 posts
Advanced Member
- LocationHouston, Texas
Posted 04 December 2011 - 09:52 PM
Thanks for posting this. A lot of great papers.
A few observations (very quick scan):
1. We're all gonna live. So many treatments are arriving that if one doesn't work there is another. Survival is just plain HUGE for all of us in CML community. We get to complain about Number 2 below.
2. Side Affects are gaining attention. It's not just: does the TKI work, but quality of life is important as an issue to be addressed. Dose is mentioned in many of these.
3. Clonal abnormalities may be of importance for Ph+ cells vs. Ph- cells as prognosticators. Pay attention to your cytogenetic reports (BM's are important - PhilB keep it clean). It's not just PCR.
And finally - very important to me:
Not a single paper, abstract, or poster on Curcumin. NONE.
Speaks volumes.
(p.s. no money to be made with Curcumin).
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
